Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
23
UNH Quote, Financials, Valuation and Earnings
Last price:
$308.84
Seasonality move
:
1.55%
Day range:
$304.79 - $313.27
52-week range:
$248.88 - $630.73
Dividend yield:
2.77%
P/E ratio:
12.88x
P/S ratio:
0.69x
P/B ratio:
2.94x
Volume:
14.2M
Avg. volume:
25.3M
1-year change:
-38.11%
Market cap:
$279.1B
Revenue:
$400.3B
EPS (TTM):
$23.88
Analysts' Opinion
-
Consensus RatingUnitedHealth Group has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 6 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $385.34, UnitedHealth Group has an estimated upside of 25.25% from its current price of $307.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $270.00 representing 100% downside risk from its current price of $307.66.
Fair Value
-
According to the consensus of 20 analysts, UnitedHealth Group has 25.25% upside to fair value with a price target of $385.34 per share.
UNH vs. S&P 500
-
Over the past 5 trading days, UnitedHealth Group has overperformed the S&P 500 by 2.02% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
UnitedHealth Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UnitedHealth Group has grown year-over-year revenues for 142 quarters straight. In the most recent quarter UnitedHealth Group reported revenues of $109.6B.
Earnings Growth
-
UnitedHealth Group has grown year-over-year earnings for 2 quarters straight. In the most recent quarter UnitedHealth Group reported earnings per share of $6.85.
Enterprise value:
336.2B
EV / Invested capital:
1.80x
Price / LTM sales:
0.69x
EV / EBIT:
10.43x
EV / Revenue:
0.82x
PEG ratio (5yr expected):
0.28x
EV / Free cash flow:
13.52x
Price / Operating cash flow:
11.45x
Enterprise value / EBITDA:
9.24x
Gross Profit (TTM):
$90.2B
Return On Assets:
7.48%
Net Income Margin (TTM):
5.39%
Return On Equity:
21.74%
Return On Invested Capital:
12.37%
Operating Margin:
8.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $335.9B | $379.5B | $410.1B | $99.8B | $109.6B | |
| Gross Profit | $83.2B | $91.3B | $90.2B | $23B | $23.8B | |
| Operating Income | $29.6B | $32.2B | $33.5B | $7.9B | $9.1B | |
| EBITDA | $33.2B | $29.1B | $36.4B | $1.8B | $10.2B | |
| Diluted EPS | $21.87 | $16.36 | $23.88 | -$1.53 | $6.85 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $59.5B | $69B | $93.9B | $88.9B | $96.3B | |
| Total Assets | $205.2B | $221.2B | $283.7B | $284.2B | $309.8B | |
| Current Liabilities | $80.6B | $88.2B | $116.5B | $104.4B | $113.5B | |
| Total Liabilities | $134.6B | $143.6B | $193.1B | $187.3B | $204.6B | |
| Total Equity | $70.6B | $77.6B | $90.6B | $96.9B | $105.2B | |
| Total Debt | $46.3B | $47.5B | $70.6B | $73.6B | $81.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $37.2B | $13.9B | $28.5B | $1.1B | $5.5B | |
| Cash From Investing | -$35.8B | -$10.9B | -$14.3B | -$6.3B | -$74M | |
| Cash From Financing | $15.1B | -$16.5B | -$11.6B | $8.2B | $99M | |
| Free Cash Flow | $34.2B | $10.5B | $24.9B | $401M | $4.6B | |
UNH
Sector
Market Cap
$279.1B
$32.6M
Price % of 52-Week High
48.78%
47.07%
Dividend Yield
2.77%
0%
Shareholder Yield
2.33%
-0.74%
1-Year Price Total Return
-38.11%
-37.62%
Beta (5-Year)
0.442
0.632
Dividend yield:
2.77%
Annualized payout:
$8.18
Payout ratio:
34.91%
Growth streak:
15 years
Technicals
8-day SMA
Buy
Level
$307.04
200-day SMA
Sell
Level
$508.65
Bollinger Bands (100)
Sell
Level
353.87 - 544.87
Chaikin Money Flow
Buy
Level
417.9M
20-day SMA
Buy
Level
$304.42
Relative Strength Index (RSI14)
Sell
Level
38.89
ADX Line
Sell
Level
35.3
Williams %R
Neutral
Level
-43.652
50-day SMA
Sell
Level
$387.18
MACD (12, 26)
Sell
Level
-17.51
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
363.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.4048)
Sell
CA Score
(Annual)
Level (-0.3766)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-0.5939)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Stock Forecast FAQ
In the current month, UNH has received 13 Buy ratings 6 Hold ratings, and 1 Sell ratings. The UNH average analyst price target in the past 3 months is $385.34.
-
Where Will UnitedHealth Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that UnitedHealth Group share price will rise to $385.34 per share over the next 12 months.
-
What Do Analysts Say About UnitedHealth Group?
Analysts are divided on their view about UnitedHealth Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UnitedHealth Group is a Sell and believe this share price will drop from its current level to $270.00.
-
What Is UnitedHealth Group's Price Target?
The price target for UnitedHealth Group over the next 1-year time period is forecast to be $385.34 according to 20 Wall Street analysts, 13 of them rate the stock a Buy, 1 rates the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is UNH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UnitedHealth Group is a Buy. 13 of 20 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of UNH?
You can purchase shares of UnitedHealth Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UnitedHealth Group shares.
-
What Is The UnitedHealth Group Share Price Today?
UnitedHealth Group was last trading at $308.84 per share. This represents the most recent stock quote for UnitedHealth Group. Yesterday, UnitedHealth Group closed at $307.66 per share.
-
How To Buy UnitedHealth Group Stock Online?
In order to purchase UnitedHealth Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 30.47% over the past day.
Buy
75
ARQQ alert for Jun 17
Arqit Quantum [ARQQ] is up 6.36% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 3.91% over the past day.
